Clinical Trial

Blink Reminders and Meibomian Gland Loss in Digital Screen Users

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized clinical trial aims to evaluate if a blink reminder program ('BlinkEasy') reduces the progression of Meibomian gland loss in intensive digital screen users over three months , using infrared meibography as the primary structural measure. Additionally, the study will analyze changes in dry eye symptoms using the 12-item Ocular Surface Disease Index (OSDI) questionnaire and non-invasive tear break-up time (NIBUT).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-18.
Trial Details
NCT Number NCT07430137
Lead Sponsor Asociación para Evitar la Ceguera en México
Conditions Dry Eye Syndromes, Meibomian Gland Dysfunction (Disorder)
Enrollment 28 participants
Start Date 2026-02-19
Primary Completion 2026-06 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-27